Company News

AI technology has brought a revolution across various industries, streamlining processes and increasing precision. In the medical field, AI is making significant strides, aiding physicians in diagnosing and treating diseases. At Getz Healthcare Taiwan, we are delighted to announce our forthcoming collaboration with Phatomics, a prominent Korean company developing AI medal software. Together, we are introducing Myomics, an automated analysis software for cardiac MR images, to Taiwan. This state-of-the-art software amalgamates clinical trials, AI, Big Data, and Radiomic research to offer fully automated analysis of cardiac MR images. The integration of these advanced technologies is expected to save time while providing dependable and highly accurate results.

On July 3rd, our business partners from Phatomics visited Taiwan to meet with physicians at National Taiwan University Hospital and Chang Gung Medical Hospital. During their visit, the installation of Myomics and product training were successfully completed. We were honored to welcome representatives from Myomics as they conducted a comprehensive product introduction and engaged in discussions, exchanging valuable clinical experiences. We are very excited to introduce this cutting-edge software to Taiwan, with an aim to establish a new standard in cardiac MR image analysis, and contribute to the advancement of the medical landscape. Venturing into this promising field, Getz Healthcare Taiwan is eager to explore the market and expand our product portfolio, furthering our commitment to delivering innovative and impactful medical solutions.